The mechanism of action of different generations of EGFR-inhibitors in malignant lung tumors. Literature review and data synthesis

Knowledge of the molecular characteristics of the progression of non-small cell lung tumors currently provides the patient with the best treatment options. One of the most well-known and studied genetic abnormalities is a mutation in the EGFR gene, which makes the tumor sensitive to therapy with tyr...

Full description

Bibliographic Details
Main Authors: Ainur F. Nasretdinov, Konstantin V. Menshikov, Alexander V. Sultanbaev, Shamil I. Musin, Nadezda I. Sultanbaeva, Irina A. Men'shikova
Format: Article
Language:Russian
Published: IP Habib O.N. 2022-11-01
Series:Современная онкология
Subjects:
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/105003/pdf